Top 10 High Growth Dividend Stocks For November 2026

The article presents 10 dividend-growth stocks screened as of November 2026 for Investment Scores of at least 70, estimated future returns of at least 12%, dividend growth of 7% or more, and payout ratios below 100%. It highlights RMD, NTES, and NVDA, attributing their estimated upside to EPS growth, dividend yield, and possible valuation mean reversion.

Analysis

The screen is a selection signal, not evidence that the stated return hurdle is achievable. The key vulnerability is the return decomposition: if a material share of the projected upside comes from valuation mean reversion, the result depends on an unverified multiple assumption rather than dividend growth alone. A payout ratio below 100% is also a weak safety test without free-cash-flow coverage, balance-sheet capacity, and a consistent definition of earnings.

The named symbols span an unspecified set of businesses, so the article does not establish sector diversification or a coherent income profile. The screen may therefore package concentrated growth, valuation, or rate sensitivity behind a dividend-growth label. Near term, the market reaction is likely limited absent the full list and a credible, independently checked methodology. Over 1–3 months, earnings revisions and cash-flow evidence matter more than the screen’s headline return estimates; over 6–18 months, persistent payout growth supported by cash generation would be the stronger thesis. The contrarian risk is that investors treat “high quality” and an attractive valuation as verified facts when both depend on undisclosed inputs.

Key Decisions for Investors

• No basket trade on this article alone. Obtain the full 10-name list, calculation date, valuation method, and return decomposition before allocating; the supplied data does not identify company mappings.
• For RMD, NTES, and NVDA, which the article names as examples, verify current dividend history, free-cash-flow coverage, payout calculation, net debt, and consensus EPS assumptions independently. Do not infer these from the screen.
• If a name survives that diligence, scale in only after checking its next earnings report and estimate revisions; favor cash-flow-supported dividend growth over upside that relies mainly on multiple expansion.
• Falsify the thesis for any candidate if guidance or consensus EPS is cut, cash-flow coverage deteriorates, or the payout breaches the screen’s stated threshold. Reassess the screen if its projected returns are not robust to flat or lower valuation multiples.